Clinical Trials Logo

Clinical Trial Summary

This is a pilot, feasibility study to evaluate, test and optimize sample analysis procedures and protocols before the full-scale, crossover study is conducted.


Clinical Trial Description

Two important factors can influence the proportions of gluten and starch that resist digestion: (1) enzyme availability and specificity and (2) the structural properties of the food. A complete evaluation of gluten digestion and of the impact of dietary supplements is difficult to conduct because it is not easy to obtain samples of digestive chime. The analysis of the ileal effluent of healthy ileostomy patients constitutes a non-invasive alternative to intubation techniques for the study of nutrient digestion and of the fate of probiotics in the small intestine. The main aim of this study is to test and optimize sample analysis protocols before conducting the full-scale, crossover study which will aim at evaluating the impact of two dietary supplements (Glutalytic® and DE111®) and of oatmeal properties on the digestion of gluten and starch and on the glycemic response. ;


Study Design


Related Conditions & MeSH terms

  • Main Focus: Gluten and Starch Digestibility

NCT number NCT04489836
Study type Interventional
Source Deerland Enzymes
Contact
Status Completed
Phase N/A
Start date August 31, 2020
Completion date September 19, 2020

See also
  Status Clinical Trial Phase
Completed NCT04489810 - Digestion of Gluten in the Presence of Enzymes N/A